PULM
Pulmatrix Inc
NASDAQ: PULM · HEALTHCARE · BIOTECHNOLOGY
$1.25
+2.33% today
Updated 2026-06-04
Market cap
$5.04M
P/E ratio
—
P/S ratio
2,459.21x
EPS (TTM)
$-1.23
Dividend yield
—
52W range
$1 – $9
Volume
0.0M
Pulmatrix Inc (PULM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $653000.00 | $352000.00 | $352000.00 | $1.20M | $835000.00 | $335000.00 | $153000.00 | $7.91M | $12.63M | $5.17M | $6.07M | $7.30M | $7.81M | $0.00 |
| Revenue growth (YoY) | — | — | -46.1% | +0.0% | +241.2% | -30.5% | -59.9% | -54.3% | +5069.9% | +59.7% | -59.1% | +17.5% | +20.2% | +7.0% | -100.0% |
| Cost of revenue | — | $8.56M | $6.59M | $6.59M | $7.19M | $10.15M | $10.24M | $12.97M | $12.85M | — | $15.38M | $1.54M | $15.52M | $7.17M | — |
| Gross profit | — | $-7.91M | $-6.24M | $-6.24M | $-5.99M | $-9.32M | $-9.91M | $-12.81M | $-4.93M | $12.63M | $-10.21M | $6.07M | $-8.22M | $640000.00 | — |
| Gross margin | — | -1211.5% | -1772.2% | -1772.2% | -498.4% | -1115.8% | -2957.6% | -8374.5% | -62.4% | 100.0% | -197.6% | 100.0% | -112.6% | 8.2% | — |
| R&D | $20000.00 | $258000.00 | $1.38M | $6.59M | $7.19M | $17.69M | $10.24M | $12.97M | $12.85M | $15.61M | $15.38M | $18.24M | $15.52M | $7.17M | $38000.00 |
| SG&A | — | $265000.00 | $1.74M | $1.74M | $9.63M | $8.02M | $7.57M | $7.52M | $8.49M | $6.89M | $6.38M | $6.78M | $6.52M | $7.79M | $5.13M |
| Operating income | $-30000.00 | $-523000.00 | $-3.12M | $-9.08M | $-23.02M | $-24.87M | $-17.48M | $-20.33M | $-20.69M | $-9.86M | $-20.17M | $-18.95M | $-14.74M | $-9.76M | $-5.17M |
| Operating margin | — | -80.1% | -885.8% | -2578.4% | -1916.6% | -2978.0% | -5216.4% | -13288.2% | -261.6% | -78.1% | -390.2% | -312.1% | -202.0% | -125.1% | — |
| EBITDA | $-30000.00 | $-523000.00 | $-3.12M | $-8.73M | $-15.39M | $-17.08M | $-17.23M | $-20.08M | $-13.24M | $-9.65M | $-16.42M | $-17.40M | $-14.61M | $-7.04M | $-5.16M |
| EBITDA margin | — | -80.1% | -885.2% | -2481.3% | -1281.1% | -2045.7% | -5143.0% | -13122.9% | -167.4% | -76.4% | -317.7% | -286.6% | -200.1% | -90.2% | — |
| EBIT | $-30000.00 | $-523000.00 | $-3.12M | $-9.08M | $-15.62M | $-17.33M | $-17.48M | $-20.31M | $-13.42M | $-9.86M | $-16.59M | $-18.95M | $-14.74M | $-7.14M | — |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $953000.00 | $881000.00 | $643000.00 | $186000.00 | $186000.00 | $0.00 | $4000.00 | $111000.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-30000.00 | $-523000.00 | $-3.12M | $-24.14M | $-26.17M | $-27.84M | $-18.06M | $-20.56M | $-20.60M | $-19.31M | $-20.17M | $-18.73M | $-14.12M | $-9.56M | $-5.16M |
| Net income growth (YoY) | — | -1643.3% | -496.2% | -674.3% | -8.4% | -6.4% | +35.2% | -13.9% | -0.2% | +6.3% | -4.5% | +7.2% | +24.6% | +32.3% | +46.0% |
| Profit margin | — | -80.1% | -885.8% | -6859.1% | -2178.8% | -3334.5% | -5389.9% | -13439.9% | -260.4% | -152.8% | -390.2% | -308.4% | -193.5% | -122.5% | — |
Frequently asked questions
What is Pulmatrix Inc's revenue?
Pulmatrix Inc's trailing twelve-month revenue is $3000.00. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How much free cash flow does PULM generate?
PULM produced $-5.43M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is PULM's balance sheet healthy?
PULM holds $4.09M in cash and equivalents against — in long-term debt, on $3.81M of shareholder equity. That debt is best read against the cash flow the business throws off each year.